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Abstract
Background:  Epidemiologic research has shown that perimenopausal contraception is an
important medical issue, because women during the perimenopause still need effective
contraception. The objective of the study was to assess the contraceptive choices of
perimenopausal Turkish women.
Methods: This is a descriptive cross-sectional study that in a non – random fashion recruited 202
perimenopausal and naturally menopausal women who lived in a suburban area of Istanbul. Women
who took part were aged between 45–59 years old. Chief database used to identify the suitable
participants in the district. Subjects who voluntarily participated in the study were interviewed in
their homes by the researcher. The analysis of the data was evaluated using percentages.
Results: The percentage of sexually active women among the participants was 87.6%. A large
majority – 80.2% – of the participants did not have any idea of when they should bring
contraception to an end. The method most commonly used was withdrawal (Coitus Interruptus),
represented by 38.8%. In regard to the participants' choices of medical contraception, those being
utilized were the IUD (24.3%), tubal sterilization (8.9%), condom (5.9%) and COC (6.4%).
Additionally, 18% of women used other traditional methods including vaginal lavage, vaginal aspirin,
and even inserting a small sponge presoaked with fresh lemon juice or cola deep into the vagina.
Among the perimenopausal women who participated, the IUD was the most popular and
appropriate contraceptive method.
Conclusion:  Most perimenopausal Turkish women are still using traditional methods and
women's knowledge about contraception in the menopausal stages is very limited. Health
professionals should provide information about perimenopausal contraception.
Background
Perimenopause marks the transition from normal ovula-
tion to anovulation and ultimately to permanent loss of
ovarian function. Fecundity, the average monthly proba-
bility of conception, declines by half as early as the mid-
forties; however, women during the perimenopause still
need effective contraception. Epidemiologic research has
shown that perimenopausal contraception is an impor-
tant medical issue [1-7]. According to the Turkey Demog-
raphy and Health Survey (TDHS) data, 23.6% and 50.1%
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of Turkish women between ages 40–44 and 45–49 respec-
tively are not protected against conception [8].
Women in their forties are still potentially fertile, and
pregnancy in this age group is attended by increased risks
of maternal mortality, spontaneous abortion, fetal abnor-
malities and perinatal mortality. The maternal mortality
rate in women in their forties is four times higher than
that among women in their twenties and the rates of
spontaneous abortion are also doubled in the forties
group [3,5,7,9,10].
There is no research on contraceptive preferences of peri-
menopausal women in Turkey. The objective of the study
was to assess the contraceptive preferences of perimeno-
pausal Turkish women.
Methods
This study was planned as a descriptive cross-sectional
research. The population of this cross-sectional study con-
sisted of women aged 45–59 years who lived in a subur-
ban area of Istanbul. The inclusion criterion for the
research sample was the history of amenorrhea for less
than 2 years among perimenopausal women aged 45–59
years. Chief database used to identify the suitable partici-
pants in the district. During the research period between
May and June 2005, 240 women who met the inclusion
criteria in the district were invited to the study and 202
women who volunteered to participate in the study were
included in the convenience sample non-randomly. Sub-
jects were interviewed in their homes by the researcher.
Turkish women's menopausal ages were taken into con-
sideration when this age group was chosen. Women who
had had a surgical menopause were excluded. Women
were informed about the aim of the study and informa-
tion about anonymity, confidentiality, and consent was
included in the explanation. The written ethical approval
was obtained from the ethical review board of the Istan-
bul University.
For gathering the data of the study a "Participant Informa-
tion Form (PIF)" was used. Demographic, gyneco-obstet-
ric and contraception characteristics were collected by the
PIF developed by researchers in a 16 – question format.
The PIF was administered by the author in face-to-face
interviews with each participant in their home.
The analysis of the data obtained from the study was car-
ried out with SPSS for Windows (Statistical Package for
Social Science for Windows Version 10.0). Data of the
study were analyzed using percentage tests.
Results
Two hundred and two women completed the study, aged
between 45 and 59 years with an overall mean age of
51.23 ± 4.17(  ± SD) years for group as a whole. The par-
ticipants were predominantly composed of married
women (87.6%), with primary school (8 years' educa-
tion) qualifications (85.4%) from a middle-income
group. The majority of them (89.7%) were housewives.
The characteristics of the participants are shown in Table
1. Three percent of the participants were nulliparous, 50%
had had 1–3 pregnancies, and 47% had had more than 3
pregnancies. The majority of participants suffered from
chronic illness such as diabetes (12.4%), cardiovascular
(34.7%), endocrine (5.4%), urological (1.5%), respira-
tory (6.9%), or musculoskeletal (10.9%) disease.
X
Table 1: Characteristics of Participants
Characteristics np e r c e n t
Sexuality
Active 177 87.6
No partner 25 12.4
Chronic Disease
Diabetes 25 12.4
Cardiovascular Disease (hypertension) 79 39.1
Other (endocrine, urologic, respiratory, muscular-skeleton) 62 30.7
Healthy (No Chronic Disease) 36 17.8
Routine gynecological control 82 40.6
Regular exercise (3 times/per week/30–60 minute) 39 19.3
Smoking ≥ 20(daily) 43 21.3
Alcohol consumption: Rarely (Social drinker) 16 8.4
Mean SD
Age (year) 51.2 4.1
Body Mass Index 28.4 4.3
Number of Births 2.6 1.4
Number of Abortions 0.4 0.8BMC Nursing 2007, 6:1 http://www.biomedcentral.com/1472-6955/6/1
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Information concerning the participants' awareness of the
correct timing of giving up contraception is presented in
Table 2. The majority of the participants did not have any
clear idea about the appropriate time for abandoning con-
traception.
Regarding the most recent contraception methods used by
the perimenopausal participants, the withdrawal method
was most often used (38.8%). Other traditional methods
were being used in a widespread manner (18%), includ-
ing vaginal lavage, vaginal Aspirin® (salisilik asit tab.), and
even the insertion of a small sponge soaked in with fresh
lemon juice or cola deep into the vagina. As far as medical
methods are concerned, the methods commonly used
were IUD (24.3%), tubal sterilization (8.9%), condom
(5.9%) and COC's (6.4%).
Discussion
Perimenopause is defined as a transition from childbear-
ing and the requirement for contraception to the infertil-
ity of menopause. According to the results of the study,
most of the perimenopausal participants were sexually
active (87.6%). The majority of participants had a chronic
disease such as diabetes, cardiovascular (hypertension),
endocrine, urological, respiratory, or musculo-skeletal
diseases. The degree of parity and other characteristics of
the participants were similar to the same age group in the
TDHS data. Generally, women living in Turkey do not
attend a gynecological clinic regularly for check ups [8].
They need counseling related to health promotion and the
regulation of fertility.
Women in their forties are still potentially fertile, and
pregnancy in this age group is attended by increased risks
of maternal mortality, spontaneous abortion, fetal anom-
alies and perinatal mortality. In developing countries,
these risks are compounded by high number of pregnan-
cies and poor medical care. A recent survey reported that
in the United States, 41% of pregnancies in women
between ages 35 and 39 years and 51% of pregnancies in
women at ages 40 years and older are unintended
[2,3,5,10,11]. According to the TDHS data, 12% of preg-
nancies in women occur between ages 40 and 44 and 2%
of pregnancies in women occur between ages 45 and 49 in
Turkey. Most of these pregnancies are unintended [8].
Four fifths of the participants did not have any idea of
when they should bring contraception to an end. Most cli-
nicians advise women to continue using contraception for
12 months after menstruation has ceased. Some recom-
mend that women less than 45 years old continue contra-
ception for 2 years after menstruation has ceased. In the
literature, it is reported that women can stop taking non-
hormonal methods after 6 months of amenorrhea if
women experience hot flushes. In the absence of classical
menopausal symptoms, however, they should wait for 12
months prior to stopping contraception use. Women
should still use contraception until the menopause
[6,7,9]. Unfortunately, the majority of the participants did
not have any clear idea about the appropriate time for
abandoning contraception, so the risk of unintended
pregnancies was high. Health professionals must use
every opportunity to give the necessary information to
perimenopausal women.
The method selected primarily was the traditional with-
drawal (38.8%) and other traditional methods. Among
the perimenopausal women, the IUD (24.3%) was the
most popular medical method. Other medical methods
being utilized were tubal sterilization (8.9%), condom
(5.9%) and COC (6.4%) (Table 2). Contraception for
women in this age group has special risks and benefits:
both should be balanced in order to choose between the
different options available.
Withdrawal which is considered to be a very common
contraceptive method nationally, is practiced at rates of
29.5% among women between ages 40 – 44 and 20.9%
among women between ages 45 – 49 [6,8].
Most perimenopausal Turkish women are still using tradi-
tional methods like a vaginal lavage, vaginal Aspirin® (ace-
tylsalicylic acid tab.), and sponge soaked in fresh lemon
juice or cola deep into the vagina. Health professionals
should provide knowledge of perimenopausal contracep-
tion, including its noncontraceptive effects and health
risks during fertility regulation counseling.
IUD usage rates in Turkey are 19.2% and 11.1% among
women between ages 40 – 45 and 45 – 49 respectively [8],
being the most commonly used medical method among
all age groups. According to the WHO's Medical Eligibility
Criteria for Contraceptive Use [12] studies done on the
Table 2: When should contraceptive methods be given up after menopause?
Contraceptive Termination Time n Percent
I don't know 162 80.2
One year later 36 17.9
Two years later 4 1.9
Total 202 100BMC Nursing 2007, 6:1 http://www.biomedcentral.com/1472-6955/6/1
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IUD -which does not have any contraindications related
to age- among users over 35 years old, showed that inci-
dences of side affects of the device on this age group were
low. In our study, IUD usage rate was higher than TDHS
(24.3%). The participants who live in Istanbul can reach
services and medical contraceptive methods more easily
than others who live in other areas[8].
At the 1994 WHO Scientific Group's menopause assem-
bly in Geneva, it was decided that the levonorgesterol
intrauterine system was a very suitable contraceptive
choice for perimenopausal women because it is associated
with minimal bleeding problems [7]. It is not a popular
contraceptive method in Turkey. It is an expensive alterna-
tive only available to attendants of private clinics [8].
According to the TDHS data, the usage rates of COC's are
3.3% among women aged 40–44 years and 1.3% among
women between ages 45–49 in Turkish women [8]. In this
study the usage rates of COC were shown to be higher
than the total of other current medical methods in Turkey
(6.4%) such as the IUD. This positive situation may be
related to the fact that the participants who live in Istan-
bul, a big city, have access to the services and medical con-
traceptive methods more easily than women in other
areas.
Recent epidemiological and clinical pharmacological
studies have indicated the safety of extending the use of
combined oral contraceptives (COCs) beyond the age of
35 years and until menopause. Decisions regarding oral
contraceptive choice should depend on many factors,
including health risks and non-contraceptive benefits. Cli-
nicians should pay attention to overweight based on BMI,
cigarette smoking and chronic diseases in Turkish peri-
menopausal women. Cardiovascular diseases, especially
diabetes and hypertensive diseases were common in the
participant women. A woman needs to consider her age,
health status, menstrual history, and sexuality, risk of sex-
ually transmitted diseases (STDs), past contraception use,
lifestyle, obstetric history, and attitude toward abortion
when choosing a contraceptive method during the peri-
menopausal years. Clinicians should educate women in
this age group about the benefits of oral contraceptives
while addressing misperceptions to allow more women
into this therapeutic option. Numerous benefits unrelated
to contraception may be attractive to women of this age
group [1,3,4,6,7,9,11,13].
Women who have reasons for avoiding COCs can use pro-
gestogen-only contraceptives like pills, depot injectables
and implants. Both copper-releasing and levonorgestrel-
releasing IUDs (LNG-IUD) combine the advantages of
high efficacy and long term effects [12]. Among perimen-
opausal women, it is only the progestin containing meth-
ods that are the least popular in Turkey (0.1%). The
pharmacies in Turkey do not currently keep the Mini Pill.
Besides, perimenopausal women in Turkey show little
interest at present in the recently introduced method,
depot enjectables [8].
Besides being a contraceptive, the condom has the added
benefit of protection against STDs. Women who are
between ages 35–39 and using the barrier method have a
1.1% risk of becoming pregnant [7]. In Turkey, the rates
of condom usage among women who are between ages
40–44 and 45–49 are 10.0% and 5.7% respectively [8].
Similarly, the rate of condom usage among perimenopau-
sal women in the study was 5.9%.
The female condom can be a source of irritation in older
age groups who may perceive themselves as unattractive
from the esthetic point of view [7]. None of the partici-
pants used the female condom, which will require special
promotional campaigns in order to become a popular
method in Turkey.
According to the TDHS data, usage rates for the dia-
phragm in Turkey are 10% among women at 40 – 44 years
old and 0.9% among women at 45 – 49 years old [8]. The
rate of diaphragm usage in this study was very low. How-
ever, the diaphragm could be an appropriate alternative
method with the advantage of having no systemic side
effects for those perimenopausal women with chronic dis-
eases. Health professionals should promote knowledge of
medical methods for contraception during fertile years.
In the United States and Australia in particular, male or
female sterilization is the most popular method of contra-
ception for women over the age of 35. Failure rates are
between 0.75% and 3.65%. In the United Kingdom, more
than 40% of couples over the age of 40 choose steriliza-
tion as a method of family planning. This is true for other
developed countries as well [[3,9],14]. According to the
TDHS data in Turkey, the female sterilization rate is
10.9% among women between ages 40 to 44 and 6.5%
among women between 45 and 49 [8]. The equivalent
rate in the study was 8.9%. Although male or female ster-
ilization has been legal since 1983, sterilization is not very
common in the Turkish population. This approach is not
viewed as a culturally acceptable method [8]. In this study
the rates of female sterilization were shown to be higher
than that currently in the rest of Turkey as a whole but
they were lower than in other countries.
Hormone Replacement Therapy (HRT) alone is not a
form of contraception, as the dosage of estrogen is not
great enough to stop ovulation from occurring. If contra-
ception is still required, a woman may safely continue tak-
ing oral contraceptives until 55 years old, whenPublish with BioMed Central    and   every 
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conception is extremely unlikely [1,7,11]. HRT use is not
widespread in Turkey [15]
Conclusion
Although many perimenopausal contraception choices
are available in Turkey, the rates of contraception use are
very low. As a result, unintended pregnancy rates are high.
Finally, contraceptive choice should be carefully guided
by considering personal and family health history, indi-
vidual preferences and previous experience. Health pro-
fessionals should promote knowledge of all medical
methods for fertility regulation during fertile years.
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